Monopar Therapeutics Inc (MNPR)
Operating Cash Flow Growth
-301322.35%
Quarterly · Period ending:
MNPR Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-301322.35%period ending
Latest reported-301322.35%period ending
MNPR Quarterly Cash from Operations YoY % (-21.00% → -301322.35%)
Year-over-year change
High-resolution chart · PNG
MNPR operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -301,322.3513% | |
| 38.6595% | |
| -68.637% | |
| -94.7398% | |
| 35.7483% | |
| -242.1069% | |
| -29.2722% | |
| 44.6596% | |
| 20.2083% | |
| 27.1096% | |
| -18.7503% | |
| 9.7122% | |
| -65.8208% | |
| 7.9589% | |
| 35.9317% | |
| -10.6712% | |
| 9.8716% | |
| -27.318% | |
| -63.7714% | |
| -49.2707% | |
| -41.2513% | |
| -72.1848% | |
| -85.5374% | |
| -112.0662% | |
| -34.5717% | |
| -13.0122% | |
| 7.8262% | |
| -2.2858% | |
| 1.7437% | |
| -23.1345% | |
| 11.0952% | |
| 49.8204% | |
| -146.7368% | |
| -159.6743% | |
| -74.6123% | |
| -462.4649% | |
| -18.5262% | |
| -20.9955% |